We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

816 hedge funds and large institutions have $36.9B invested in Regeneron Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 200 funds opening new positions, 281 increasing their positions, 254 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more first-time investments, than exits

New positions opened: 200 | Existing positions closed: 79

38% more funds holding in top 10

Funds holding in top 10: 16 → 22 (+6)

33% more capital invested

Capital invested by funds: $27.7B → $36.9B (+$9.19B)

16% more funds holding

Funds holding: 702 → 816 (+114)

11% more repeat investments, than reductions

Existing positions increased: 281 | Existing positions reduced: 254

1.63% more ownership

Funds ownership: 68.47% → 70.11% (+1.6%)

9% more call options, than puts

Call options by funds: $1.04B | Put options by funds: $959M

Holders
816
Holders Change
+114
Holders Change %
+16.24%
% of All Funds
17.98%
Holding in Top 10
22
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+37.5%
% of All Funds
0.48%
New
200
Increased
281
Reduced
254
Closed
79
Calls
$1.04B
Puts
$959M
Net Calls
+$83.4M
Net Calls Change
+$234M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.16B
2
Fidelity International
Fidelity International
Bermuda
+$197M
3
BlackRock
BlackRock
New York
+$189M
4
N
Nuveen
North Carolina
+$177M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$89.2M

Top Sellers

Rank Fund Capital Flow
1
Harris Associates
Harris Associates
Illinois
-$846M
2
Capital World Investors
Capital World Investors
California
-$495M
3
HL
Harding Loevner
New Jersey
-$244M
4
Citadel Advisors
Citadel Advisors
Florida
-$154M
5
HM
HealthCor Management
New York
-$140M
Name Holding Trade Value Shares
Change 		Change in
Stake
QIM
826
Quantitative Investment Management
Virginia
– -$6.6M -17,572 Closed
OAC
827
OMERS Administration Corp
Ontario, Canada
– -$6.01M -16,000 Closed
Capstone Investment Advisors
828
Capstone Investment Advisors
New York
– -$5.96M -14,438 Closed
HI
829
HBK Investments
Texas
– -$4.83M -12,870 Closed
BAM
830
Blueshift Asset Management
New Jersey
– -$4.14M -11,019 Closed
MWA
831
Marshall Wace Asia
Hong Kong
– -$3.7M -9,854 Closed
TC
832
TwinBeech Capital
New York
– -$3.57M -9,507 Closed
BCM
833
Bayesian Capital Management
New York
– -$2.94M -7,830 Closed
AIM
834
Achmea Investment Management
Netherlands
– -$2.22M -5,903 Closed
Wolverine Trading
835
Wolverine Trading
Illinois
– -$2.18M -5,833 Closed
FC
836
FORA Capital
Florida
– -$1.98M -5,278 Closed
HPCM
837
High Pointe Capital Management
Illinois
– -$1.74M -4,640 Closed
ACM
838
Asymmetry Capital Management
California
– -$1.72M -4,584 Closed
OAM
839
Oxford Asset Management
United Kingdom
– -$1.6M -4,252 Closed
HF
840
HRT Financial
New York
– -$1.43M -3,815 Closed
Verition Fund Management
841
Verition Fund Management
Connecticut
– -$1.32M -3,528 Closed
DC
842
Diametric Capital
Massachusetts
– -$1.07M -2,846 Closed
TCM
843
Teza Capital Management
Illinois
– -$1.05M -2,809 Closed
WCM
844
Weld Capital Management
New York
– -$1.05M -2,805 Closed
GTCM
845
Gyon Technologies Capital Management
New Jersey
– -$876K -2,334 Closed
TI
846
Trexquant Investment
Connecticut
– -$743K -1,980 Closed
KC
847
Kepos Capital
New York
– -$743K -1,979 Closed
KCM
848
Kingdon Capital Management
New York
– -$714K -1,901 Closed
TRCT
849
Tower Research Capital (TRC)
New York
– -$680K -1,811 Closed
AP
850
Advisors Preferred
Maryland
– -$581K -1,547 Closed
32 33
34
35 36

REGN Hedge Fund Activity: Q1 2020 in Review

816 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q1 2020, worth a combined $36.9B — up 33% from $27.7B a quarter earlier.

Buyers outnumbered sellers: 200 funds opened new REGN positions and 79 closed out — a net gain of 121 holders — while 281 added to existing stakes and 254 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $2.16B. The largest seller was Harris Associates, cutting an estimated $846M.

  • 816 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q1 2020, up from 702 in Q4 2019.
  • Funds reported $36.9B of Regeneron Pharmaceuticals stock for Q1 2020, up 33% quarter-over-quarter.
  • 200 funds opened new Regeneron Pharmaceuticals positions in Q1 2020 and 79 closed out, a net change of +121 holders.
  • The largest Regeneron Pharmaceuticals buyer in Q1 2020 was Fidelity Investments, an estimated $2.16B added.
  • The largest Regeneron Pharmaceuticals seller in Q1 2020 was Harris Associates, an estimated $846M sold.

Based on aggregated 13F filings for Q1 2020.